The Ensign Group (NASDAQ:ENSG) Rating Lowered to Hold at Wall Street Zen

Key Points

• Wall Street Zen downgraded The Ensign Group to “Hold” from “Buy.” Despite the downgrade, the broader analyst consensus remains “Moderate Buy,” with four Buy ratings, two Holds and a $216.25 average price target.
• Ensign reported quarterly EPS of $1.92, beating estimates of $1.80, while revenue rose 16.7% year over year to $1.44 billion. The stock opened at $176.63, with a 12-month range of $141.58 to $218.00.
• Legal risks are adding uncertainty: investor-rights firms are soliciting shareholders for a pending securities class action alleging misleading disclosures by the company and certain executives, with a lead-plaintiff deadline of December 7, 2026.

The Ensign Group (NASDAQ:ENSG - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report released on Saturday, Wall Street Zen reports.

A number of other research analysts also recently commented on ENSG. Truist Financial increased their target price on The Ensign Group from $202.00 to $207.00 and gave the company a "hold" rating in a research report on Thursday, July 30th. Royal Bank Of Canada restated an "outperform" rating and issued a $228.00 price target on shares of The Ensign Group in a research report on Tuesday, July 28th. Finally, Weiss Ratings raised shares of The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a research note on Thursday, October 8th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $216.25.

The Ensign Group Price Performance

NASDAQ:ENSG opened at $176.63 on Friday. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $10.29 billion, a P/E ratio of 27.68, a P/E/G ratio of 1.69 and a beta of 0.66. The Ensign Group has a 12 month low of $141.58 and a 12 month high of $218.00. The business's 50-day moving average is $175.42 and its 200 day moving average is $175.59.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last announced its quarterly earnings results on Monday, July 27th. The company reported $1.92 EPS for the quarter, beating analysts' consensus estimates of $1.80 by $0.12. The company had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.44 billion. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%. The firm's revenue was up 16.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.59 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. On average, equities research analysts forecast that The Ensign Group will post 7.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director John Agwunobi sold 392 shares of the stock in a transaction on Monday, July 20th. The shares were sold at an average price of $171.06, for a total value of $67,055.52. Following the sale, the director owned 9,503 shares of the company's stock, valued at approximately $1,625,583.18. This represents a 3.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On The Ensign Group

Several hedge funds have recently added to or reduced their stakes in ENSG. USA Financial Formulas bought a new position in The Ensign Group in the 3rd quarter valued at $38,000. Pension & Wealth Management Advisors Inc. purchased a new stake in The Ensign Group in the third quarter worth $86,000. Davidson Capital Management Inc. lifted its position in shares of The Ensign Group by 3.4% during the third quarter. Davidson Capital Management Inc. now owns 31,496 shares of the company's stock worth $5,417,000 after purchasing an additional 1,037 shares during the last quarter. Fort Washington Investment Advisors Inc. OH lifted its position in shares of The Ensign Group by 40.2% during the third quarter. Fort Washington Investment Advisors Inc. OH now owns 195,540 shares of the company's stock worth $33,633,000 after purchasing an additional 56,023 shares during the last quarter. Finally, NorthCrest Asset Manangement LLC lifted its position in shares of The Ensign Group by 6.9% during the third quarter. NorthCrest Asset Manangement LLC now owns 10,074 shares of the company's stock worth $1,728,000 after purchasing an additional 647 shares during the last quarter. 96.12% of the stock is currently owned by institutional investors.

Key The Ensign Group News

Here are the key news stories impacting The Ensign Group this week:

• Neutral Sentiment: Investors who purchased Ensign securities between February 10, 2022, and June 18, 2026, may seek appointment as lead plaintiff in the pending federal class action. The deadline to file that motion is December 7, 2026. Kaplan Fox announcement
• Negative Sentiment: Multiple investor-rights firms, including Rosen Law Firm, Kaplan Fox, Robbins Geller and others, are soliciting investors in connection with the same lawsuit. The repeated announcements increase the visibility of the allegations and add to investor uncertainty. Rosen Law Firm announcement
• Negative Sentiment: The complaint alleges that Ensign and certain executives made false or misleading statements or failed to disclose material information during the class period. These are allegations, not established findings, but potential legal damages, defense costs, management distraction and reputational harm can weigh on valuation. Robbins Geller announcement

About The Ensign Group

The Ensign Group, Inc NASDAQ: ENSG is a healthcare services company that operates through a network of skilled nursing, rehabilitation and senior living facilities. Its centers provide post-acute care, including nursing services, physical, occupational and speech therapy, short-term rehabilitation, and long-term residential care for older adults and patients recovering from illness, injury or surgery.

The company also provides home health and hospice services, as well as a range of ancillary services supporting post-acute care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.